Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.
about
Targeting disease through novel pathways of apoptosis and autophagyShedding new light on neurodegenerative diseases through the mammalian target of rapamycinPRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotectionA Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.Therapeutic targets for cancer: current concepts with PI 3-K, Akt, & mTOR.Ron and its expanding role in tumor carcinogenesis.FOXO1: Another avenue for treating digestive malignancy?RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells.The role of AP-1 in self-sufficient proliferation and migration of cancer cells and its potential impact on an autocrine/paracrine loop
P2860
Q26864639-E25890BE-2DF3-418E-8596-9F0D90E9F9BBQ27015640-4C3B93DB-2BE7-42F2-AA5E-08EDA2039A90Q34429082-D9A0E70F-58CA-4BE6-B59E-2E3FE1AA3AE5Q36379761-A0B694C2-ED18-4A13-81A9-D3F8C9723D20Q36887780-B4D5B967-24A1-4F92-8A43-6C60CC76714DQ37707571-E7018619-3169-44EB-87B5-866BE935CD61Q38543678-F6544B58-F197-4A26-ADB7-9A68AC051DFDQ38922319-1613ECCE-157B-4DC7-A0D2-04C3254D6942Q43158408-308FF233-D004-462E-8E26-B47C3F87D714Q44605323-69953D09-6D83-4954-9353-7E5398F1CDC4Q47613328-CBC182B7-4E4D-4A3E-A248-B3506106F525Q54979788-6FF93EC9-665D-4829-BE28-6C3085E94D9FQ57821073-9FF8A7A8-C030-437C-8E30-D2CD44460CB0
P2860
Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@en
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@nl
type
label
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@en
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@nl
prefLabel
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@en
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@nl
P2093
P2860
P1476
Knockdown of RON inhibits AP-1 ...... human colorectal cancer cells.
@en
P2093
Cho-Yun Chung
Gi-Hoon Lee
Ho-Seok Ki
Kang-Jin Park
Kyu-Yeol Kim
Kyung-Keun Kim
Sung-Bum Cho
Wan-Sik Lee
Young-A Song
P2860
P2888
P304
P356
10.1007/S10620-011-1892-7
P577
2011-09-08T00:00:00Z